MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-33-0085918
Svizera Labs Private Limited
Svizera Labs Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹142.05 Cr
▲ 7% YoY
Net profit · FY 2022
₹10.56 Cr
Net margin 7.4%
EBITDA · FY 2022
₹13.83 Cr
EBITDA margin 9.7%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹2.8 Cr
Issued & subscribed
Open charges
₹100 Cr
Satisfied ₹88.84 Cr
Company age
29 yrs
Est. 1997
Employees · EPFO
60
Provident fund records
About Svizera Labs Private Limited
Data last updated:
Svizera Labs Private Limited is a private limited company based in Thane, Maharashtra, India, a subsidiary of Maneesh Pharmaceuticals Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 April 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH1997PTC107389. Its GSTIN is 27AAFCS5547N1ZQ (Maharashtra).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.8 Cr. It was formerly known as Trident Cleaning and Warehousing Private Limited. It is led by directors including Maneesh Ramakant Sapte and Pareshkumar Pravinchandra Upadhyay.
Its last annual general meeting (AGM) was held on 11 July 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2022, the company reported a revenue of ₹142.05 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹10.56 Cr (net margin 7.4%) and EBITDA of ₹13.83 Cr (EBITDA margin 9.7%). Revenue has grown at a compounded annual rate (CAGR) of 54% over three years and 66% over five years.
The company has about 60 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹100 Cr and satisfied charges of ₹88.84 Cr on record. Court records list 13 cases involving the company, including 6 filed by the company and 7 filed against it; 2 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in September 2008. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Immacule Lifesciences Private Limited with revenue of ₹143.18 Cr.
Svizera Labs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0085918). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999MH1997PTC107389
Registration Number 107389
Incorporation Date 17 April 1997
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 11 July 2023
Date of Balance Sheet 31 March 2023
Parent Company Maneesh Pharmaceuticals Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-33-0085918
CIN history
Svizera Labs has one previous CIN (Corporate Identification Number): U99999MH1997PTC107389. The current CIN is U74999MH1997PTC107389, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999MH1997PTC107389 | Current |
| U99999MH1997PTC107389 | Previous |
Key People
Maneesh Ramakant Sapte Director Pareshkumar Pravinchandra Upadhyay Director Rashmi Vinay Sapte Director Recognitions & Rankings of Svizera Labs
Contact details
Svizera Labs Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No D – 16/6, Ttc – MIDC Ind. Area Turbhe, Thane, Maharashtra, India – 400703
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Svizera Labs Private Limited, buy the company report.
Comprehensive company report
Svizera Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Svizera Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Svizera Labs Private Limited, buy the company report.
Financials of Svizera Labs Private Limited
FY 2023 filings availableSvizera Labs Private Limited reported revenue of ₹142.05 Cr (up 7% YoY) for FY 2022.
Revenue · FY 2022
₹142.05 Cr ▲ 7%
Net profit · FY 2022
₹10.56 Cr margin 7.4%
EBITDA · FY 2022
₹13.83 Cr margin 9.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 54%
5 years · compounded
▲ 66%
EBITDA CAGR growth
3 years · compounded
▲ 160%
5 years · compounded
▲ 47%
Revenue has grown at a compounded annual rate (CAGR) of 66% over five years, including 7% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.83 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.56 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.7% | ||||
| Net Profit Margin | 7.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Svizera Labs Private Limited, buy the company report.
Board of directors of Svizera Labs Private Limited
Svizera Labs has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maneesh Ramakant Sapte | Director | 13 Nov 2000 | 25 Years 11 Months | Current |
| Pareshkumar Pravinchandra Upadhyay | Director | 28 Nov 2019 | 6 Years 10 Months | Current |
| Rashmi Vinay Sapte Also directs: Phaarmasia Limited, Maneesh Pharmaceuticals Limited, Zypcare Lifesciences Private Limited and 3 more | Director | 09 Apr 1999 | 27 Years 6 Months | Current |
| Vinay Ramakant Sapte | Director | 01 Apr 2002 | 24 Years 6 Months | Current |
Peer comparison
Svizera Labs Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Immacule Lifesciences Private Limited | ₹143.18 Cr (FY 2025) | 34.0% | Nalagarh, Himachal Pradesh, India | |||
| Alventa Pharma Limited | ₹142.72 Cr (FY 2025) | 82.0% | Kolkata, West Bengal, India | |||
| Apotex Pharmachem India Private Limited | ₹142.14 Cr (FY 2024) | -19.0% | Bangalore, Karnataka, India | |||
| Sovereign Pharma Private Limited | ₹142.09 Cr (FY 2025) | 15.0% | Mumbai, Maharashtra, India | |||
| Svizera Labs Private Limitedthis company | ₹142.05 Cr (FY 2022) | ₹10.56 Cr | 7.4% | 7.0% | 60 | Thane, Maharashtra, India |
| Ratnatris Pharmaceuticals Private Limited | ₹141.71 Cr (FY 2025) | 35.0% | Ahmedabad, Gujarat, India | |||
| Lyka Labs Limited | ₹140.73 Cr (FY 2025) | 25.0% | Ankleshwar, Gujarat, India | |||
| Aglowmed Limited | ₹139.55 Cr (FY 2025) | 11.0% | Patna, Bihar, India | |||
| Jackson Laboratories Private Limited | ₹139.35 Cr (FY 2024) | 14.0% | Punjab, India |
To see the full peer comparison of Svizera Labs Private Limited, buy the company report.
Auditor
Svizera Labs Private Limited is audited by M. Nanday & Co. for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M. Nanday & Co. | FY 2021 |
Shareholding
The shareholding of Svizera Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Svizera Labs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹100 Cr
Satisfied charges
₹88.84 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jul 2025 | 101158151 | Others | ₹100 Cr | Open | |
| 30 Jun 2009 | 10168697 | Citi Bank N.A. | ₹80 Cr | Satisfied | |
| 22 Dec 2005 | 90354411 | Vijaya Bank | ₹3 Cr | Satisfied | |
| 28 Mar 2005 | 90353611 | Vijaya Bank | ₹1.88 Cr | Satisfied | |
| 29 Sep 2000 | 90352850 | The Bharat Co-Op Bank Ltd | ₹3.96 Cr | Satisfied |
To see the full charge records of Svizera Labs Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Svizera Labs Private Limited has 1 deal on record (1 secondary share transfer); the latest was in September 2008.
Total deals
1
Secondary share transfer
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2008 | Secondary share transfer | Undisclosed | Buyer: Maneesh Pharmaceuticals Limited & Vinay Ramakant Sapte, Maneesh Pharmaceuticals Limited Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Svizera Labs Private Limited has 13 court cases on record: 6 filed by Svizera Labs, 7 filed against it. 2 cases are pending and 11 are disposed.
Total cases
13
Filed by the company
6
Filed against the company
7
Pending
2
Disposed
11
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 8 | 2 | 1 |
| District courts | 5 | 5 | 1 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Complaint ULP) | Filed against the company by an individual | Pending |
| Bombay High Court | Writ petition | Filed by the company against The State of Maharashtra, Through the Chief Secretary and Ors. | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by an individual | Disposed |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against individuals | Disposed |
| High Court, TAMIL NADU | Court case (CRL MP) | Filed by the company against Union of India | Disposed |
To see the full case history of Svizera Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Svizera Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Svizera Labs has 2 associated companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
2
Associated companies
Employees & EPFO
Svizera Labs Private Limited has a workforce of 60 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
60
Active EPFO establishments
1
Employee growth
15.38%
GST
Svizera Labs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCS5547N1ZQ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Svizera Labs Private Limited, buy the company report.
Recent activity
Svizera Labs Private Limited has 6 board changes on record since 1999: 5 appointments and 1 cessation. The latest: Pareshkumar Pravinchandra Upadhyay ceased to be Additional Director on 28 Sep 2020.
Charges
A charge with Others amounted to Rs. 100.00 Cr with Charge ID 101158151 was registered on 28 Jul 2025.
AGM
Svizera Labs Private Limited last Annual general meeting of members was held on 11 Jul 2023 as per latest MCA records.
Filing
Svizera Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Ceased
Pareshkumar Pravinchandra Upadhyay ceased to be Additional Director.
Appointed
Pareshkumar Pravinchandra Upadhyay was appointed as Director.
Appointed
Rakesh Khetan Tunaram was appointed as Manager.
Charges
A charge registered on 22 Dec 2005 via Charge ID 90354411 with Vijaya Bank was fully satisfied on 25 Jul 2014.
Charges
A charge registered on 28 Mar 2005 via Charge ID 90353611 with Vijaya Bank was fully satisfied on 25 Jul 2014.
Charges
A charge registered on 30 Jun 2009 via Charge ID 10168697 with Citi Bank N.A. was fully satisfied on 29 Oct 2013.
Charges
A charge with Citi Bank N.A. of Rs. 80.00 Cr registered on 30 Jun 2009 with Charge ID 10168697 was modified on 20 Feb 2010.
Charges
A charge with Citi Bank N.A. amounted to Rs. 80.00 Cr with Charge ID 10168697 was registered on 30 Jun 2009.
Charges
A charge with Vijaya Bank of Rs. 1.88 Cr registered on 28 Mar 2005 with Charge ID 90353611 was modified on 25 Aug 2008.
8 earlier events are in the company report.
Frequently asked questions
Svizera Labs is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 April 1997 (29+ years old) and is registered under CIN U74999MH1997PTC107389.
Svizera Labs has 4 current directors:
- Maneesh Ramakant Sapte - Director
- Pareshkumar Pravinchandra Upadhyay - Director
- Rashmi Vinay Sapte - Director
- Vinay Ramakant Sapte - Director
The latest financial statements of Svizera Labs on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 11 July 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Svizera Labs is 27AAFCS5547N1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Svizera Labs is U74999MH1997PTC107389. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Svizera Labs has 13 court cases on record: 6 filed by the company and 7 filed against it. 2 are pending. Most are in the high courts.
Svizera Labs was incorporated on 17 April 1997, making it 29+ years old. It is registered with the Registrar of Companies, Mumbai.
Svizera Labs has 1 deal on record (1 secondary share transfer); the latest was in September 2008.
The peers of Svizera Labs by revenue are Immacule Lifesciences Private Limited, Alventa Pharma Limited, Apotex Pharmachem India Private Limited, Sovereign Pharma Private Limited, Ratnatris Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pareshkumar Pravinchandra Upadhyay ceased to be Additional Director on 28 Sep 2020. Pareshkumar Pravinchandra Upadhyay was appointed as Director on 28 Nov 2019. Rakesh Khetan Tunaram was appointed as Manager on 04 Mar 2019. Svizera Labs has 6 board changes on record in total.
Yes, Svizera Labs is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-33-0085918).